PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
Phase of Trial: Phase I/II
Latest Information Update: 19 Mar 2018
At a glance
- Drugs CLR 1404 I-124 (Primary)
- Indications Glioblastoma
- Focus Diagnostic use
- 20 Feb 2018 Status changed from active, no longer recruiting to completed.
- 23 Jan 2018 Planned End Date changed from 1 Jun 2015 to 1 Jun 2019.
- 23 Jan 2018 Status changed from discontinued to active, no longer recruiting.